Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemi...

Por El Sahly, H. M., Patel, S. M., Atmar, R. L., Lanford, T. A., Dube, T., Thompson, D., Sim, B. K. L., Long, C., Keitel, W. A.
Publicado em 2010

A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy ad...

Por Keitel, W.A., Potter, G.E., Diemert, D., Bethony, J., El Sahly, H.M., Kennedy, J.K., Patel, S.M., Plieskatt, J.L., Jones, W., Deye, G., Bottazzi, M.E., Hotez, P.J., Atmar, R.L.
Publicado no Vaccine (2019)